This tool was designed to help you assess the grade of the adverse event reported by your patient and to get dosing modifications recommendations based on the grade of the event as per the approved IBRANCE Prescribing Information. How to use this tool?
- Step 1: select an adverse event (see most common adverse reactions below, please use our search functionality or switch to view the full list)
- Step 2: assess the grade of the adverse event as per CTCAE 4.0 criteria
- Step 3: determine appropriate dosing modifications strategies
If you need additional information (including the incidence of the adverse events occurring in the pivotal palbociclib randomized clinical trials), please consult the approved IBRANCE® capsules Prescribing Information or IBRANCE® tablets Prescribing Information, search through our collection of approved scientific response documents or contact us directly (submit a request online, or call 1-800-438-1985).